Member

Shionogi Inc.


Since its founding in 1878, Shionogi has been dedicated to developing innovative treatments to improve the lives of patients worldwide. The company focuses on addressing global health challenges, including antimicrobial resistance and COVID-19, through a commitment to scientific excellence and strategic partnerships.

Industries

biotechnology
medical-device
pharmaceutical
product-research

Nr. of Employees

Very Large (1000+)

Shionogi Inc.


Patents

Solid dispersions

2020-03-24 • US-10596118-B2

View Details

Modified release amoxicillin products

2014-07-15 • US-8778924-B2

View Details

Robust pellet

2014-06-24 • US-8758820-B2

View Details

Tablet for pulsed delivery

2014-05-06 • US-8715727-B2

View Details

Products

Antibiotics

Shionogi developed an antibiotic targeting multidrug resistant Gram-negative bacteria, addressing a major global public health concern.

HIV Therapy

As part of ViiV Healthcare, Shionogi developed two significant HIV medications in the last decade.

Influenza Treatment and Prevention

Shionogi discovered an antiviral drug for treating and preventing influenza virus infections.

COVID-19

Shionogi is focused on addressing challenges posed by COVID-19 as part of its commitment to combating infectious diseases.

Serious Fungal Infection

Shionogi is working on antifungal agents to address unmet needs caused by drug-resistant aspergillus and other rare mould infections.

Women's Health

Shionogi developed a therapy for vulvar and vaginal atrophy, a condition occurring post-menopause.

Expertise Areas

  • Drug discovery and development
  • Antimicrobial drug development
  • Vaccine development
  • Pharmaceutical manufacturing and engineering
  • Show More (8)

Key Technologies

  • GLP testing frameworks
  • Field agronomic trial design
  • Controlled-environment (greenhouse) studies
  • Artificial rainfall and environmental simulation
  • Show More (5)

Key People

Nathan McCutcheon

President and Chief Executive Officer

LinkedIn

David Benadon

Senior Vice President, Chief Human Resources Officer

LinkedIn

Margaret Borys

Executive Vice President and Chief Commercial Officer

LinkedIn

Masahiro Fujita

Senior Vice President and Chief Financial Officer

LinkedIn

Tadashi Hara

Executive Vice President and Chief Global Operations Officer

LinkedIn

Chris Klein

Senior Vice President and General Counsel

LinkedIn

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.